Showing results (151-160 of 313) with videos related to

Sort By:
Pageof 32
Biochemical Pharmacology|February 4, 2006
In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promisesJohn O Miners, Kathleen M Knights, J Brian Houston, et al.
Biochemical and Biophysical Research Communications|July 15, 1993
cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamilyC J Jin, J O Miners, K J Lillywhite, et al.
Ecology|April 4, 2009
Modeling species occurrence dynamics with multiple states and imperfect detectionDarryl I MacKenzie, James D Nichols, Mark E Seamans, et al.
Biochemical and Biophysical Research Communications|June 2, 2006
Fatty acyl-CoA as an endogenous activator of UDP-glucuronosyltransferasesKazuharu Okamura, Yuji Ishii, Shin-Ichi Ikushiro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 3, 2009
Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10Oranun Kerdpin, Peter I Mackenzie, Kushari Bowalgaha, et al.
The Journal of Laryngology and Otology|November 1, 1996
Audio-vestibular manifestations of Chiari malformation and outcome of surgical decompression: a case reportA U Ahmmed, I Mackenzie, V K Das, et al.
British Journal of Neurosurgery|January 1, 1989
A low cost system for performing CT stereotaxic brain biopsyB A Bell, R Howard, A I Mackenzie, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2015
Induction of UDP-glucuronosyltransferase 2B15 gene expression by the major active metabolites of tamoxifen, 4-hydroxytamoxifen and endoxifen, in breast cancer cellsApichaya Chanawong, Dong Gui Hu, Robyn Meech, et al.
Pageof 32